N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide

C26H24Cl2N4O5 — CID 504982

IUPACN-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide
SMILESCOc1ccnc(C(=O)CC(=O)N(Cc2ccc(Cl)c(Cl)c2)c2ccc(C(=O)N3CCOCC3)cc2)n1
InChIInChI=1S/C26H24Cl2N4O5/c1-36-23-8-9-29-25(30-23)22(33)15-24(34)32(16-17-2-7-20(27)21(28)14-17)19-5-3-18(4-6-19)26(35)31-10-12-37-13-11-31/h2-9,14H,10-13,15-16H2,1H3
InChIKeyKSULZNDGUAHZDT-UHFFFAOYSA-N
MW543.41 g/mol
LogP4.07
Rot. Bonds8

About N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide

N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide (PubChem CID 504982) has the molecular formula C26H24Cl2N4O5 and a molecular weight of 543.41 g/mol. Its IUPAC name is N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide.

Molecular Properties

Compound NameN-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide
PubChem CID504982
Molecular FormulaC26H24Cl2N4O5
Molecular Weight543.41 g/mol
Exact Mass542.11
IUPAC NameN-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide
SMILESCOc1ccnc(C(=O)CC(=O)N(Cc2ccc(Cl)c(Cl)c2)c2ccc(C(=O)N3CCOCC3)cc2)n1
InChIInChI=1S/C26H24Cl2N4O5/c1-36-23-8-9-29-25(30-23)22(33)15-24(34)32(16-17-2-7-20(27)21(28)14-17)19-5-3-18(4-6-19)26(35)31-10-12-37-13-11-31/h2-9,14H,10-13,15-16H2,1H3
InChIKeyKSULZNDGUAHZDT-UHFFFAOYSA-N
XLogP4.07
TPSA101.93 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500543.41
LogP ≤ 54.07
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide?
The IUPAC name of N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide (CID 504982) is N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide.
What is the SMILES notation for N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide?
The canonical SMILES for N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide is COc1ccnc(C(=O)CC(=O)N(Cc2ccc(Cl)c(Cl)c2)c2ccc(C(=O)N3CCOCC3)cc2)n1.
What is the InChIKey of N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide?
The InChIKey is KSULZNDGUAHZDT-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24Cl2N4O5/c1-36-23-8-9-29-25(30-23)22(33)15-24(34)32(16-17-2-7-20(27)21(28)14-17)19-5-3-18(4-6-19)26(35)31-10-12-37-13-11-31/h2-9,14H,10-13,15-16H2,1H3.
What are the key properties of N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide?
N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide has a molecular weight of 543.41 g/mol, XLogP of 4.07, 8 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3,4-dichlorophenyl)methyl]-3-(4-methoxypyrimidin-2-yl)-N-[4-(morpholine-4-carbonyl)phenyl]-3-oxopropanamide is sourced from PubChem (CID 504982), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).